| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5813745 | Neuropharmacology | 2015 | 8 Pages |
•There are no efficient pharmacological tools to study the Ca2+ channel CALHM1.•We discovered the benzothiazapine CGP37157 blocks CALHM1 at low concentrations.•4,1-benzothiazepines are the first family of organic compounds modulating CALHM1.•The S-enantiomer of a new derivative of CGP, ITH12575, blocked CALHM1 at 1 μM.
CALHM1 is a Ca2+ channel discovered in 2008, which plays a key role in the neuronal electrical activity, among other functions. However, there are no known efficient blockers able to modulate its Ca2+ handling ability. We herein describe that benzothiazepine CGP37157 and its newly synthesized analogue ITH12575 reduced Ca2+ influx through CALHM1 at low micromolar concentrations. These results could serve as a starting point for the development of more selective CALHM1 ligands using CGP37157 as a hit compound, which would help to study the physiological role of CALHM1 in the control of [Ca2+]cyt in excitable cells, as well as its implication in CNS diseases.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
